WARRANT AGENT AGREEMENT – OFFERING WARRANTSWarrant Agent Agreement • September 16th, 2022 • Felicitex Therapeutics Inc. • Pharmaceutical preparations • New York
This WARRANT AGENT AGREEMENT (this “Warrant Agreement”) dated as of [●], 2022 (the “Issuance Date”) is between Felicitex Therapeutics Inc., a Delaware corporation (the “Company”), and VStock Transfer, LLC (the “Warrant Agent”).
RESTRICTED STOCK AWARD AGREEMENTRestricted Stock Award Agreement • September 16th, 2022 • Felicitex Therapeutics Inc. • Pharmaceutical preparations • Delaware
This Restricted Stock Award Agreement (this “Agreement”) is made and entered into as of _______________ (the “Grant Date”) by and between Felicitex Therapeutics Inc., a Delaware corporation (the “Company”), and ______________ (the “Grantee”).
STOCK OPTION AGREEMENTStock Option Agreement • September 16th, 2022 • Felicitex Therapeutics Inc. • Pharmaceutical preparations • Delaware
This Stock Option Agreement (this “Agreement”) is made and entered into as of the Grant Date specified below by and between Felicitex Therapeutics Inc., a Delaware corporation (the “Company”), and the participant named below (the “Participant”).
RESTRICTED STOCK UNIT AWARD AGREEMENTRestricted Stock Unit Award Agreement • September 16th, 2022 • Felicitex Therapeutics Inc. • Pharmaceutical preparations • Delaware
This Restricted Stock Unit Award Agreement (this “Agreement”) is made and entered into as of _______________ (the “Grant Date”) by and between Felicitex Therapeutics Inc., a Delaware corporation (the “Company”), and ______________ (the “Grantee”).
ContractFelicitex Therapeutics Inc. • September 16th, 2022 • Pharmaceutical preparations • New York
THE REGISTERED HOLDER OF THIS PURCHASE WARRANT BY ITS ACCEPTANCE HEREOF, AGREES THAT IT WILL NOT SELL, TRANSFER OR ASSIGN THIS PURCHASE WARRANT EXCEPT AS HEREIN PROVIDED AND THE REGISTERED HOLDER OF THIS PURCHASE WARRANT AGREES THAT IT WILL NOT SELL, TRANSFER, ASSIGN, PLEDGE OR HYPOTHECATE THIS PURCHASE WARRANT FOR A PERIOD OF ONE HUNDRED EIGHTY DAYS FOLLOWING [●], 2022 (THE “EFFECTIVE DATE”) TO ANYONE OTHER THAN (I) AEGIS CAPITAL CORP. OR A SELECTED DEALER IN CONNECTION WITH THE OFFERING FOR WHICH THIS PURCHASE WARRANT WAS ISSUED TO THE UNDERWRITER AS CONSIDERATION (THE “OFFERING”), OR (II) A BONA FIDE OFFICER OR PARTNER OF AEGIS CAPITAL CORP.
THIS EXHIBIT HAS BEEN REDACTED TO REMOVE INFORMATION THAT IS NOT MATERIAL AND THAT THE REGISTRANT MUST TREAT AS PRIVATE AND CONFIDENTIAL.** FELICITEX MATERIAL TRANSFER AGREEMENTFelicitex Material Transfer Agreement • September 16th, 2022 • Felicitex Therapeutics Inc. • Pharmaceutical preparations • Massachusetts
This Felicitex Material Transfer Agreement (this “Agreement”) is dated July 18, 2022 and is by and between Felicitex Therapeutics, Inc., a Delaware corporation, located at 27 Strathmore Rd, Natick, MA 01760 (“‘Felicitex”) and Barbara Ann Karmanos Cancer Institute, a Michigan nonprofit corporation, located at 4100 John R, Detroit, MI 48201 (“Recipient”) (together with Felicitex, “Parties” and each, a “Party”).
Underwriting AgreementUnderwriting Agreement • September 16th, 2022 • Felicitex Therapeutics Inc. • Pharmaceutical preparations • New York
Letter AgreementLetter Agreement • September 16th, 2022 • Felicitex Therapeutics Inc. • Pharmaceutical preparations • Massachusetts
This letter agreement summarizes the terms and conditions upon which A.T. Healey, LLC (“Company” or “ATH”) will provide FELICITEX THERAPEUTICS INC. (“Client”) outsourced accounting and finance services.
